Landon Capital

Landon capital

Capital Market News, Capital Markets Now

RFL+

0.0533 USD

+ 136.89%
CDTX

217.71 USD

+ 105.41%
FTW+

1.09 USD

+ 84.75%
BCGWW

0.0719 USD

+ 83.42%
CLNNW

0.0069 USD

+ 64.29%
CYCUW

0.08 USD

+ 63.93%
XBPEW

0.0493 USD

+ 57.51%
CYPH

2.75 USD

+ 56.25%
SRZNW

0.0148 USD

+ 55.79%
SVREW

0.0231 USD

+ 51.97%
CYCU

6.32 USD

+ 51.20%
MSPRZ

0.0312 USD

+ 44.44%
SHMDW

0.8997 USD

+ 41.69%
TOIIW

0.23 USD

+ 41.54%
DSYWW

0.032 USD

+ 39.13%
FGIWW

0.0705 USD

+ 36.63%
CMCT

9.25 USD

+ 36.43%
HTOOW

0.018 USD

+ 36.36%
NIVFW

0.0223 USD

+ 35.98%
MOBBW

2.29 USD

+ 34.71%

Top Gainer

Latest News

Let’s make a deal, Merck (NYSE: MRK) to acquire Cidara for $9.2 billion  Merck (NYSE: MRK) announced it will acquire Cidara Therapeutics (CDTX) for $221.50 per share in cash, valuing the transaction at approximately $9.2 billion. The acquisition centers on Cidara’s lead candidate CD388, an investigational antiviral agent currently in Phase 3 trials for influenza prevention. CD388 is designed to …